Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Calne

Showing results (91-100 of 315) with videos related to

Pageof 32
Sort By:
Neurotoxicology|July 1, 1999
Manganese neurotoxicity: a review of clinical features, imaging and pathologyP K Pal, A Samii, D B Calne
Brain : a Journal of Neurology|March 1, 1981
Reaction time in Parkinson's diseaseE V Evarts, H Teräväinen, D B Calne
Clinical Neuropharmacology|January 1, 1984
Assessment of Parkinson's diseaseT A Larsen, S Calne, D B Calne
Lancet (London, England)|December 14, 1985
(+)-4-Propyl-9-hydroxynaphthoxazine (PHNO), a new dopaminomimetic, in treatment of parkinsonismA J Stoessl, E Mak, D B Calne
Annals of Human Genetics|October 1, 1974
Hereditary motor and sensory polyneuropathy (peroneal muscular atrophy)P K Thomas, D B Calne, G Stewart
Neurology|July 1, 1983
Olfactory impairment in Parkinson's diseaseC D Ward, W A Hess, D B Calne
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 1, 1993
A scoring error in the Mini-Mental State testM Schulzer, D B Calne, B Snow, et al.
Advances in Neurology|January 1, 1983
Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studiesP A LeWitt, R S Burns, D B Calne
Anaesthesia|January 1, 1973
Cardiovascular reactions to anaesthesia during treatment with levodopaD R Bevan, P S Monks, D B Calne
British Journal of Pharmacology|May 1, 1975
Hypothermic action of bromocriptineD B Calne, L E Claveria, J L Reid
Pageof 32

Showing results (91-100 of 315) with videos related to

Sort By:
Pageof 32
Neurotoxicology|July 1, 1999
Manganese neurotoxicity: a review of clinical features, imaging and pathologyP K Pal, A Samii, D B Calne
Brain : a Journal of Neurology|March 1, 1981
Reaction time in Parkinson's diseaseE V Evarts, H Teräväinen, D B Calne
Clinical Neuropharmacology|January 1, 1984
Assessment of Parkinson's diseaseT A Larsen, S Calne, D B Calne
Lancet (London, England)|December 14, 1985
(+)-4-Propyl-9-hydroxynaphthoxazine (PHNO), a new dopaminomimetic, in treatment of parkinsonismA J Stoessl, E Mak, D B Calne
Annals of Human Genetics|October 1, 1974
Hereditary motor and sensory polyneuropathy (peroneal muscular atrophy)P K Thomas, D B Calne, G Stewart
Neurology|July 1, 1983
Olfactory impairment in Parkinson's diseaseC D Ward, W A Hess, D B Calne
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 1, 1993
A scoring error in the Mini-Mental State testM Schulzer, D B Calne, B Snow, et al.
Advances in Neurology|January 1, 1983
Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studiesP A LeWitt, R S Burns, D B Calne
Anaesthesia|January 1, 1973
Cardiovascular reactions to anaesthesia during treatment with levodopaD R Bevan, P S Monks, D B Calne
British Journal of Pharmacology|May 1, 1975
Hypothermic action of bromocriptineD B Calne, L E Claveria, J L Reid
Pageof 32